• Harvard-MIT’s Broad Institute Powers Genomic Research in the Cloud

    Wall Street Journal | Genomic researchers at more than 100 public and private institutions comb 70 petabytes of data aiming to advance the understanding and treatment of human disease and lay the groundwork for new therapies.

    Mar 14, 2018

  • Flu Déjà Vu

    Bio-IT World | A century after influenza terrorized the planet, a harsh flu season and the looming threat of another pandemic is helping spur efforts toward a more powerful “universal” vaccine.

    Mar 14, 2018

  • From App Store To Drug Store, Digital Health Is Redefining Pharma’s Pipeline

    STAT | Backed by a growing body of evidence, software is itself becoming a prescription for diseases ranging from depression to heart disease, and drug companies are starting to take notice.

    Mar 13, 2018

  • Rob Brainin Named New CEO at WuXi NextCODE

    Bio-IT World News Brief | WuXi NextCODE has named a new CEO: Rob Brainin, Executive Vice President and Chief Operating Officer, has been appointed as the company’s new Chief Executive Officer effective today. Brainin succeeds Hannes Smárason, who will work as a senior advisor for the company as he pursues other entrepreneurial activities, according to the company.

    Mar 12, 2018

  • AI Has a Hallucination Problem Thats Proving Tough to Fix

    WIRED | Machine learning systems, like those used in self-driving cars, can be tricked into seeing objects that don't exist. Defenses proposed by Google, Amazon, and others are vulnerable too.

    Mar 9, 2018

  • WuXi NextCODE Announces Genomics Partnership with Google Cloud

    Bio-IT World  | WuXi NextCODE today announced a partnership with Google Cloud. WuXi NextCODE’s core suite of capabilities—including GORdb, WuXi NextCODE secondary analysis, the Sequence Miner case-control research application, and the Clinical Sequence Analyzer clinical interpretation system—will be hosted on Google Cloud and available on the Google Cloud Launcher marketplace.

    Mar 7, 2018

  • FDA Authorizes 23andMe BRCA Consumer Test

    Bio-IT World News Brief | FDA today authorized a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian, and prostate cancer.

    Mar 6, 2018

  • Ballot is Open For 2018 Benjamin Franklin Award Winner

    Bio-IT World Bioinformatics.org has announced five finalists for the 2018 Benjamin Franklin Award for Open Access in the Life Sciences, including the first finalist team. Voting will be open until Monday, March 12. Finalists are Christine Durinx, SIB Swiss Institute of Bioinformatics & Johanna McEntyre, EMBL-EBI; Melissa Haendel, Oregon Health and Science University; Desmond Higgins, University College Dublin (UCD) Conway Institute; B.F. Francis Ouellette, Ontario Institute of Cancer Research; and Frank W. Rockhold, Duke University Medical Center.

    Mar 5, 2018

  • The Latest in Data Integration and Personalized Medicine: Updates from the 2018 Molecular Medicine Tri-Conference

    Bio-IT World  In San Francisco last month, Bio-IT World caught up with leaders in data management and cloud computing at Tri-Con’s Converged IT & the Cloud track. In a series of talks and panel discussions, they shared their experiences dealing with the challenges of storing, transferring and integrating vast amounts of data from a broad range of sources.

    Mar 5, 2018

  • The Man Who Uncovered a New (Old) Way to Fight Cancer

    MIT Technology Review | Matthew Vander Heiden helped revive the forgotten- but critical-study of cancer metabolism.

    Mar 5, 2018

  • NIH, Inova Launch 10K-Person Database For Re-Contact

    Bio-IT World News Brief | The National Institutes of Health and Inova Health System today announced The Genomic Ascertainment Cohort (TGAC), a two-year pilot project that will allow researchers to re-contact genotyped people and examine the genes and gene variants' influence on their phenotypes, an individual's observable traits, such as height, eye color or blood type.

    Mar 1, 2018

  • 23andMe Adds 120 New Regions To Its Ancestry Test

    CNBC | At-home DNA testing company 23andMe is including 120 new regions in its ancestry report, making the test far more specific in its results.

    Feb 28, 2018

  • Dovetail Genomics, Illumina, The Broad Institute, And More: News From February 2018

    Bio-IT World | February featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Dovetail Genomics, Illumina, The Broad Institute, and more.

    Feb 28, 2018

  • Leroy Hood On How Systems-Driven 21st Century Medicine Could Transform Healthcare

    Diagnostics World | During the 25th annual Molecular Medicine Tri-Conference in San Francisco, Leroy Hood of the Institute for Systems Biology and Providence St. Joseph Health discussed his latest efforts to transform medicine through pioneering a systems-driven approach.

    Feb 27, 2018

  • GA4GH Releases 2018 Strategic Roadmap

    Bio-IT World | The Global Alliance for Genomics and Health has announced their Strategic Roadmap, which the organization hopes will aid in the major shift toward genomics becoming useful in healthcare.

    Feb 26, 2018

  • Changing Cancer Research: Biden Cancer Initiative On What’s Next

    Bio-IT World | Gregory Simon, President of the Biden Cancer Initiative, discussed the current state of cancer treatment during his keynote address at the 25th annual Molecular Medicine Tri-Conference last week. “What I’m going to talk to you about today,” Simon said, “is changing the way we think about what we’re doing in [cancer] research.”

    Feb 23, 2018

  • Share The Data: David Haussler Envisions A New Future For Pediatric Cancer

    Bio-IT World | David Haussler, Professor and Scientific Director of the UC Santa Cruz Genomics Institute, came to the 25th annual Molecular Medicine Tri-Conference to discuss using the power of big data to help pediatric cancer patients.

    Feb 22, 2018

  • CRISPR In China: Cancer Treatment With Gene Editing Underway

    NPR | More than a third of patients with cancer of the esophagus responded to experimental treatment in China with the gene-editing technique CRISPR. Several CRISPR studies are underway there.

    Feb 21, 2018

  • 100,000 Genomes Project Reaches Halfway Milestone

    Bio-IT World Brief | The United Kingdom’s pioneering 100,000 Genomes Project has reached a major milestone by sequencing 50,000 genomes.

    Feb 20, 2018

  • Doctors Said Immunotherapy Would Not Cure Her Cancer. They Were Wrong.

    The New York Times | Scientists are racing to understand why immunotherapy drugs have worked for a few cancer patients when the medicines should have had no effect.

    Feb 19, 2018